Aurora and medreleaf australia launch indimed tempo 26, further strengthening product offerings for medical cannabis patients

Edmonton, ab, april 12, 2023 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb), the canadian company opening the world to cannabis, and medreleaf australia today announced the launch of indimed tempo 26, a range of new higher thc dried cannabis products for qualified patients under the medreleaf concession scheme (mcs). tempo 26 will add to the portfolio of products available, giving doctors the ability to prescribe from a wider range of options for medical cannabis patients.
ACB Ratings Summary
ACB Quant Ranking